Review Article

Adjuvant chemotherapy and radiotherapy in the treatment of non-small cell lung cancer (NSCLC)

Bojan Zaric, Vladimir Stojsic, Aleksandar Tepavac, Tatjana Sarcev, Paul Zarogoulidis, Kaid Darwiche, Kosmas Tsakiridis, Ilias Karapantzos, Georgios Kesisis, Ioanna Kougioumtzi, Nikolaos Katsikogiannis, Nikolaos Machairiotis, Aikaterini Stylianaki, Christophoros N. Foroulis, Konstantinos Zarogoulidis, Branislav Perin

Abstract

Lung cancer is one of the most common human malignancies and remains the leading cause of cancer related deaths worldwide. Many recent technological advances led to improved diagnostics and staging of lung cancer. With development of new treatment options such as targeted therapies there might be improvement in progression free survival of patients with advanced stage non-small cell lung cancer (NSCLC). Improvement in overall survival is still reserved for selected patients and selected treatments. One of the mostly investigated therapeutic options is adjuvant treatment. There are many open issues in selection of patients and administration of appropriate adjuvant treatment.

Article Options

Download Citation

Share